Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model
Alexis Hofherr, Julie Williams, Li‐Ming Gan, et al.
BMC Nephrology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions
Rajesh Kumar Jha, Sara Lopez-Trevino, Haritha R. Kankanamalage, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1098-1098
Open Access | Times Cited: 17
NF‐κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation
Mohammad Yasin Zamanian, Hashem O. Alsaab, Maryam Golmohammadi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 15
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection
Alessio Mazzieri, Francesca Porcellati, Francesca Timio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3969-3969
Open Access | Times Cited: 13
Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy
Jingjing He, Boxin Liu, Xiaofeng Du, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy
Liping Bao, Yuhan Gong, Wenfang Xu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316615-e0316615
Open Access | Times Cited: 1
Endoplasmic Reticulum Stress in Renal Cell Carcinoma
Marta Correia de Sousa, Etienne Delangre, Miranda Türkal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4914-4914
Open Access | Times Cited: 15
Perturbational phenotyping of human blood cells reveals genetically determined latent traits associated with subsets of common diseases
Max Homilius, Wandi Zhu, Samuel S. Eddy, et al.
Nature Genetics (2023) Vol. 56, Iss. 1, pp. 37-50
Open Access | Times Cited: 13
Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease
Alexis Hofherr, Elena Liarte Marin, Barbara Musiał, et al.
Kidney International Reports (2024) Vol. 9, Iss. 6, pp. 1876-1891
Open Access | Times Cited: 5
Association of neutrophil–lymphocyte ratio, platelet–lymphocyte ratio and monocyte‐to‐high‐density lipoprotein ratio with diabetic nephropathy
Gulru B. Sonmezoz, Mürvet Yılmaz
Therapeutic Apheresis and Dialysis (2025)
Closed Access
Uncoupling protein 1-mediated protective effects of β3-adrenergic receptor agonist on kidney fibrosis via promoting adipose tissue browning in diabetic mice
Kunsheng Zhao, Linlin Meng, Xinlu Wang, et al.
International Journal of Biological Macromolecules (2025), pp. 142977-142977
Closed Access
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
Akihiko Koshino, Brendon L. Neuen, Niels Jongs, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease
Vivek Akhouri, Syamantak Majumder, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 321, pp. 121643-121643
Closed Access | Times Cited: 9
Quality of Life of Dialysis Patients: Exploring the Influence of Membrane Hemocompatibility and Dialysis Practices on Psychosocial and Physical Symptoms
Victoria Doan, Ahmed Shoker, Amira Abdelrasoul
Journal of Composites Science (2024) Vol. 8, Iss. 5, pp. 172-172
Open Access | Times Cited: 2
Role of inflammation in the progression of diabetic kidney disease
Arunita Chatterjee, Jacqueline Tumarin, Sharma Prabhakar
Vessel Plus (2024)
Open Access | Times Cited: 2
CXCL5 inhibition improves kidney function by protecting renal tubular epithelial cells in diabetic kidney disease
Ching Chen, Liang‐Yu Lin, Yen‐Wen Wu, et al.
Clinical Immunology (2024), pp. 110369-110369
Closed Access | Times Cited: 2
Exercise as a therapeutic approach to alleviate diabetic kidney disease: mechanisms, clinical evidence and potential exercise prescriptions
Rao Fan, Jianda Kong, Jiahao Zhang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
Pasquale Esposito, Daniela Picciotto, Francesca Cappadona, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 10, pp. 1450-1462
Open Access | Times Cited: 6
Protective Effect of Saikosaponin D against Streptozotocin-Induced Diabetic Nephropathy in Rats by Regulating the Oxidative Stress and Inflammatory Markers
Yan Chen, Guanglu Zhang, Rijing Liang, et al.
Indian Journal of Pharmaceutical Education and Research (2024) Vol. 58, Iss. 3, pp. 882-889
Open Access | Times Cited: 1
Molecular mechanisms and therapeutic potential of natural flavonoids in diabetic nephropathy: Modulation of intracellular developmental signaling pathways
Mahaboob Khan Sulaiman
Current Research in Pharmacology and Drug Discovery (2024) Vol. 7, pp. 100194-100194
Open Access | Times Cited: 1
Proanthocyanidin offers protection against diabetic nephropathy: elucidation of its mechanism of action using animal models
Dengpiao Xie, Huan Wang, Qing Ji, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 702-712
Open Access | Times Cited: 1
An immunocompetent human kidney on-a-chip model to study renal inflammation and immune-mediated injury
Linda Gijzen, Marleen Bokkers, Richa Hanamsagar, et al.
Biofabrication (2024) Vol. 17, Iss. 1, pp. 015040-015040
Open Access | Times Cited: 1
MD Simulation Studies for Selective Phytochemicals as Potential Inhibitors against Major Biological Targets of Diabetic Nephropathy
Mohd Adnan Kausar, Sadaf Anwar, Wafa Ali Eltayb, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4980-4980
Open Access | Times Cited: 6
Dysregulated coagulation system links to inflammation in diabetic kidney disease
Mengyun Xiao, Donge Tang, Shaodong Luan, et al.
Frontiers in Clinical Diabetes and Healthcare (2023) Vol. 4
Open Access | Times Cited: 3
Metformin reduces insulin resistance and attenuates progressive renal injury in prepubertal obese Dahl salt-sensitive rats
Ubong S. Ekperikpe, Sautan Mandal, S. J. Holt, et al.
AJP Renal Physiology (2023) Vol. 325, Iss. 3, pp. F363-F376
Open Access | Times Cited: 2
Diabetic nephropathy: Ayur‐nutri‐pharmaco approach
Kounaina Khan, Subrahmanya Padyana
Food Safety and Health (2024) Vol. 2, Iss. 3, pp. 344-361
Open Access
Page 1 - Next Page

Scroll to top